|
Maximum valid dilution (MVD)
|
|
0
|
229
|
January 30, 2024
|
|
RLAF in dispensing area
|
|
2
|
804
|
January 28, 2024
|
|
Process validation Blend uniformity sampling-Solids
|
|
5
|
1309
|
January 22, 2024
|
|
Procedure of OOS
|
|
5
|
903
|
January 19, 2024
|
|
Endotoxins and moist heat sterilization
|
|
5
|
448
|
January 18, 2024
|
|
Product Quality Review
|
|
0
|
319
|
January 17, 2024
|
|
Environment for Mixing and Holding tanks
|
|
1
|
302
|
January 17, 2024
|
|
Reference standard qualification
|
|
0
|
404
|
January 13, 2024
|
|
What is the main reason for impurity C in Rosuvastatin tablets
|
|
0
|
250
|
January 12, 2024
|
|
URS AND CHANGE in system
|
|
3
|
545
|
January 10, 2024
|
|
Responsibility of QA and QC
|
|
9
|
1468
|
January 9, 2024
|
|
D value (Biological Indicator)
|
|
3
|
559
|
January 8, 2024
|
|
Survival /Kill time ( Biological Indicator)
|
|
3
|
440
|
January 8, 2024
|
|
Microscope- oil immersion
|
|
0
|
186
|
January 8, 2024
|
|
Can I prepare one common process Validation Protocol for 2 different batch size of same product & area
|
|
2
|
582
|
January 6, 2024
|
|
SOP for Ointment mixer
|
|
0
|
231
|
January 5, 2024
|
|
HVAC validation
|
|
1
|
768
|
January 5, 2024
|
|
How assay of API decrease with moisture content is there any trend or authentic reference?
|
|
2
|
567
|
January 4, 2024
|
|
Specimen signature
|
|
1
|
355
|
January 4, 2024
|
|
Biological indicator
|
|
18
|
3341
|
January 9, 2024
|
|
Use different API in one production batch
|
|
5
|
586
|
January 8, 2024
|
|
QC test as per Pharmacopoeia
|
|
1
|
604
|
December 29, 2023
|
|
Load patterns for sterilization
|
|
13
|
2200
|
December 29, 2023
|
|
Specific guidelines for employing logbooks in the pharmaceutical industry
|
|
7
|
820
|
December 24, 2023
|
|
Material transfer between clean rooms
|
|
0
|
295
|
December 13, 2023
|
|
What is Room temperature definition?
|
|
0
|
564
|
December 13, 2023
|
|
Leak test apparatus
|
|
0
|
505
|
December 12, 2023
|
|
How to calculate boiler requirements?
|
|
0
|
270
|
December 12, 2023
|
|
Rotation of 2 Disinfectants (having "generally" similar modes of action and some differences in target sites) in sterile pharmaceutical production area in the context of the new Global GMP Guideline (EU Annex 1 (2022))
|
|
0
|
210
|
December 11, 2023
|
|
Lamitube for Ointment
|
|
5
|
422
|
December 10, 2023
|